We have developed and are preparing to market an innovative prostate imaging system known as the ProUroScan™ System. The ProUroScan System creates images and documents abnormalities of the prostate using our new, proprietary mechanical elasticity imaging technology. The ProUroScan System is an imaging system designed for use as an aid to the physician in documenting abnormalities in the prostate that have been previously detected by a digital rectal exam (“DRE”). As an adjunct to DRE, the ProUroScan System will be used following an abnormal DRE to generate a real-time image of the prostate. On April 27, 2012, the ProUroScan™ received initial clearance for marketing in the United States from the United States Food and Drug Administration (“FDA”).
Company profile
Ticker
PUMD
Exchange
CEO
Stanton D. Myrum
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • GE HealthCare • Uber • The Kraft Heinz Company • Lineage • Boston Scientific • American Water Works • Organon & Co. • Life Time • Teleflex ...
Former names
Global Internet Communications Inc
SEC CIK
Corporate docs
IRS number
201212923
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
26 Feb 15
EFFECT
Notice of effectiveness
21 Mar 14
15-12G
Securities registration termination
14 Mar 14
8-K
Other Events
12 Mar 14
POS AM
Prospectus update (post-effective amendment)
12 Mar 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Mar 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Mar 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Mar 14
8-K
Departure of Directors or Certain Officers
12 Feb 14
10-Q
2013 Q3
Quarterly report
14 Nov 13